Downloads
Abstract
Objectives: Explore clinical symptoms and tests, evaluate the efficacy of surgery in the treatment of Bethesda IV thyroid nodules and review histopathological results.
Methods: 52 patients with Bethesda IV thyroid nodules in Hue University of Medicine and Pharmacy Hospital from 01/01/2021 to 30/07/2022.
Results: 96,2% are female. The average age is 43,3 ± 13,6. 75% patients hospitalized without any symptoms. Tumors distribute equally in 2 lobes. The average dimension is 2,0 ± 1,2cm. Sensitivity and specific of TIRADS is 60,9% and 89,7%, respectively. 51,9% patients underwent total thyroidectomy, 42,3% patients underwent lobectomy. Complete thyroidectomy was conducted in 14,8% cases. Surgical complications in this research were transient hypoparathyroidism (13,5%), permanent hypoparathyroidism (3,8%), transient recurrent laryngeal nerve paralysis (1,9%) and seroma (1,9%). 44,2% cases was malignant. The most common histopathology types were: Papillary carcinoma (36,5%), colloid nodules (30,8%), follicular adenoma (17,3%), follicular variant of papillary carcinoma (5,8%).
Conclusions: Surgery is a curative type of treatments in Bethesda IV thyroid nodules. Besides, surgery play an important role in histopathology diagnosis. The complications of thyroid surgery is equivalent to other studies.
References
Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977; 7(6): 481-93.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209-249.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26(1): 1-133.
Cibas ES, Ali SZ, Conference NCITFSotS. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009; 132(5): 658-65.
Fernandez-Trujillo C, Perez-Zaballos J, Rodriguez-Perez CA, Lopez-Plasencia Y, Marrero-Arencibia D, Cabrera-Galvan JJ, et al. TSH Level and Risk of Malignancy in Patients with Bethesda Category IV Thyroid Nodules. Horm Cancer. 2020; 11(3-4): 200-204.
Huân NTT. Cắt giáp toàn phần trong điều trị carcinoma tuyến giáp biệt hoá tốt. Tạp chí Y học Lâm Sàng. 2016;37: 58-67.
Phướng P. Bước đầu đánh giá kết quả phẫu thuật ung thư tuyến giáp. Tạp chí y học Lâm Sàng số 18/2013. 2013: 37-42.
Yang J, Schnadig V, Logrono R, Wasserman PG. Fine needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111(5): 306-315.
Godoi Cavalheiro B, Kober Nogueira Leite A, Luongo de Matos L, Palermo Miazaki A, Marcel Ientile J, Aurelio VKM, et al. Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center. Int J Endocrinol Metab. 2018; 16(1): e12871.
Deniwar A, Hambleton C, Thethi T, Moroz K, Kandil E. Examining the Bethesda criteria risk stratification of thyroid nodules. Pathol Res Pract. 2015; 211(5): 345-348.
Kakudo K, Higuchi M, Hirokawa M, Satoh S, Jung CK, Bychkov A. Thyroid FNA cytology in Asian practice-Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinomas. Cytopathology. 2017; 28(6): 455-466.
Zahid A, Shafiq W, Nasir KS, Loya A, Abbas Raza S, Sohail S, et al. Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective. J Clin Transl Endocrinol. 2021; 23.
| Published | 26-12-2024 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 91 (2023) | |
| Section | Original article | |
| DOI | 10.38103/jcmhch.91.15 | |
| Keywords | Bethesda IV, U tuyến giáp Bethesda IV, Thyroid nodules |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Journal of Clinical Medicine Hue Central Hospital